135 related articles for article (PubMed ID: 32452738)
1. Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.
Bismeijer T; van der Velden BHM; Canisius S; Lips EH; Loo CE; Viergever MA; Wesseling J; Gilhuijs KGA; Wessels LFA
Radiology; 2020 Aug; 296(2):277-287. PubMed ID: 32452738
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomic Analysis of Breast Cancer by Using B-Mode and Vascular US and RNA Sequencing.
Park AY; Han MR; Park KH; Kim JS; Son GS; Lee HY; Chang YW; Park EK; Cha SH; Cho Y; Hong H; Cho KR; Song SE; Woo OH; Lee JH; Cha J; Seo BK
Radiology; 2020 Apr; 295(1):24-34. PubMed ID: 32013793
[TBL] [Abstract][Full Text] [Related]
3. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
Yamamoto S; Maki DD; Korn RL; Kuo MD
AJR Am J Roentgenol; 2012 Sep; 199(3):654-63. PubMed ID: 22915408
[TBL] [Abstract][Full Text] [Related]
4. Enhancing patterns of breast cancer on preoperative dynamic contrast-enhanced magnetic resonance imaging and resection margin in breast conserving therapy.
Kim OH; Kim SJ; Lee JS
Breast Dis; 2016 Feb; 36(1):27-35. PubMed ID: 27177341
[TBL] [Abstract][Full Text] [Related]
5. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
[TBL] [Abstract][Full Text] [Related]
6. Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation.
Wu J; Sun X; Wang J; Cui Y; Kato F; Shirato H; Ikeda DM; Li R
J Magn Reson Imaging; 2017 Oct; 46(4):1017-1027. PubMed ID: 28177554
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
[TBL] [Abstract][Full Text] [Related]
9. Preoperative breast MRI features associated with positive or close margins in breast-conserving surgery.
Bae MS; Bernard-Davila B; Sung JS; Morris EA
Eur J Radiol; 2019 Aug; 117():171-177. PubMed ID: 31307644
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
[TBL] [Abstract][Full Text] [Related]
11. Identification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study.
Kang JH; Youk JH; Kim JA; Gweon HM; Eun NL; Ko KH; Son EJ
Korean J Radiol; 2018; 19(5):897-904. PubMed ID: 30174479
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma.
Zhu Y; Li H; Guo W; Drukker K; Lan L; Giger ML; Ji Y
Sci Rep; 2015 Dec; 5():17787. PubMed ID: 26639025
[TBL] [Abstract][Full Text] [Related]
13. Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.
Ragusi MAA; Bismeijer T; van der Velden BHM; Loo CE; Canisius S; Wesseling J; Wessels LFA; Elias SG; Gilhuijs KGA
Breast; 2021 Dec; 60():230-237. PubMed ID: 34763270
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
15. Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?
van der Velden BHM; Bismeijer T; Canisius S; Loo CE; Lips EH; Wesseling J; Viergever MA; Wessels LFA; Gilhuijs KGA
Eur J Radiol; 2019 Dec; 121():108705. PubMed ID: 31655316
[TBL] [Abstract][Full Text] [Related]
16. MRI predictors of tumor-positive margins after breast-conserving surgery.
Bahl M; Baker JA; Kinsey EN; Ghate SV
Clin Imaging; 2019; 57():45-49. PubMed ID: 31128385
[TBL] [Abstract][Full Text] [Related]
17. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications.
Zhou M; Leung A; Echegaray S; Gentles A; Shrager JB; Jensen KC; Berry GJ; Plevritis SK; Rubin DL; Napel S; Gevaert O
Radiology; 2018 Jan; 286(1):307-315. PubMed ID: 28727543
[TBL] [Abstract][Full Text] [Related]
18. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
[TBL] [Abstract][Full Text] [Related]
19. Surgical Outcomes for Ductal Carcinoma in Situ: Impact of Preoperative MRI.
Yoon GY; Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
Radiology; 2020 May; 295(2):296-303. PubMed ID: 32181727
[TBL] [Abstract][Full Text] [Related]
20. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
Wang C; Wei W; Santiago L; Whitman G; Dogan B
Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
